Decisions 18th October 2016


At the meeting that took place on 18th October, the folllowing decisions were agreed.

 

New Drug Requests

Approved

Dermatonics Heel balm® (TLS Blue)

  • Approved for inclusion onto the formulary for diabetic patients at risk from ulceration under recommendation from podiatry services.

Betamethasone and calcipotriol (Enstilar® foam) (TLS Green)

  • Approved for inclusion onto the formulary for the topical treatment of body psoriasis vulagaris in adults.

Esomeprazole granules (TLS Blue)

  • Approved for inclusion onto the formulary for paediatric patients with NG tubes, or second line in children with swallowing difficulties.

 

Other 

Guanfacine

  • The JFG discussed the application but agreed to await the applicant to be present at the next meeting to make a final decision.  

Rituximab

  • The JFG agreed for rituximab in TTP to be included on the formulary for TTP as previously aagreed at the Commissioning Advisiory forum in 2011. 

Shared Care Protocols/TLS Change in Status

None

 

Last updated by: on 20-12-2016 18:35